140 related articles for article (PubMed ID: 27510251)
1. SLCO1B1 gene polymorphisms do not influence plasma rifampicin concentrations in a South Indian population.
Ramesh K; Hemanth Kumar AK; Kannan T; Vijayalakshmi R; Sudha V; Manohar Nesakumar S; Bharathiraja T; Lavanya J; Swaminathan S; Ramachandran G
Int J Tuberc Lung Dis; 2016 Sep; 20(9):1231-5. PubMed ID: 27510251
[TBL] [Abstract][Full Text] [Related]
2. The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications.
Chigutsa E; Visser ME; Swart EC; Denti P; Pushpakom S; Egan D; Holford NH; Smith PJ; Maartens G; Owen A; McIlleron H
Antimicrob Agents Chemother; 2011 Sep; 55(9):4122-7. PubMed ID: 21709081
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of SLCO1B1 Gene in Sundanese Ethnic Population of Tuberculosis Patients in Indonesia.
Santoso P; Juliastuti H; Nataprawira HM; Soeroto AY; Alisjahbana B; Ruslami R; Debora J; Sribudiani Y; Maskoen AM
Acta Med Indones; 2022 Oct; 54(4):517-523. PubMed ID: 36624704
[TBL] [Abstract][Full Text] [Related]
4. Anthropometric and Genetic Factors Associated With the Exposure of Rifampicin and Isoniazid in Mexican Patients With Tuberculosis.
Huerta-García AP; Medellín-Garibay SE; Salazar-González RA; Ortiz-Álvarez A; Magaña-Aquino M; Rodríguez-Pinal CJ; Portales-Pérez DP; Romano-Moreno S; Milán-Segovia RDC
Ther Drug Monit; 2019 Oct; 41(5):648-656. PubMed ID: 30939588
[TBL] [Abstract][Full Text] [Related]
5. SLCO1B1 and SLC10A1 polymorphism and plasma rifampin concentrations in patients with co-morbidity tuberculosis-diabetes mellitus in Baja California, Mexico.
Perea-Jacobo R; Muñiz-Salazar R; Laniado-Laborín R; Zenteno-Cuevas R; Cabello-Pasini A; Ochoa-Terán A; Radilla-Chávez P
Tuberculosis (Edinb); 2022 Sep; 136():102248. PubMed ID: 36055153
[TBL] [Abstract][Full Text] [Related]
6. Variability in plasma rifampicin concentrations and role of
Sileshi T; Makonnen E; Telele NF; Barclay V; Zumla A; Aklillu E
Infect Dis (Lond); 2024 Apr; 56(4):308-319. PubMed ID: 38315168
[TBL] [Abstract][Full Text] [Related]
7. Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations.
Weiner M; Peloquin C; Burman W; Luo CC; Engle M; Prihoda TJ; Mac Kenzie WR; Bliven-Sizemore E; Johnson JL; Vernon A
Antimicrob Agents Chemother; 2010 Oct; 54(10):4192-200. PubMed ID: 20660695
[TBL] [Abstract][Full Text] [Related]
8. A population approach of rifampicin pharmacogenetics and pharmacokinetics in Mexican patients with tuberculosis.
Medellin-Garibay SE; Huerta-García AP; Rodríguez-Báez AS; Magaña-Aquino M; Ortiz-Álvarez A; Portales-Pérez DP; Milán-Segovia RDC; Romano-Moreno S
Tuberculosis (Edinb); 2020 Sep; 124():101982. PubMed ID: 32810723
[TBL] [Abstract][Full Text] [Related]
9. Low rifampicin concentrations in tuberculosis patients with HIV infection.
Gengiah TN; Botha JH; Soowamber D; Naidoo K; Abdool Karim SS
J Infect Dev Ctries; 2014 Aug; 8(8):987-93. PubMed ID: 25116663
[TBL] [Abstract][Full Text] [Related]
10. Effect of Genetic Variation of
Dompreh A; Tang X; Zhou J; Yang H; Topletz A; Adu Ahwireng E; Antwi S; Enimil A; Langaee T; Peloquin CA; Court MH; Kwara A
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263072
[TBL] [Abstract][Full Text] [Related]
11. Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients.
Mukonzo JK; Kengo A; Kutesa B; Nanzigu S; Pohanka A; McHugh TD; Zumla A; Aklillu E
Trans R Soc Trop Med Hyg; 2020 Feb; 114(2):107-114. PubMed ID: 31789383
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetic Study of Drugs Affecting Mycobacterium tuberculosis.
Shabani S; Farnia P; Ghanavi J; Velayati AA; Farnia P
Int J Mycobacteriol; 2024 Apr; 13(2):206-212. PubMed ID: 38916393
[TBL] [Abstract][Full Text] [Related]
13. Relationship among genetic polymorphism of SLCO1B1, rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosis.
Kim ES; Kwon BS; Park JS; Chung JY; Seo SH; Park KU; Song J; Yoon S; Lee JH
Br J Clin Pharmacol; 2021 Sep; 87(9):3492-3500. PubMed ID: 33538008
[TBL] [Abstract][Full Text] [Related]
14. CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India.
Ramachandran G; Hemanth Kumar AK; Rajasekaran S; Kumar P; Ramesh K; Anitha S; Narendran G; Menon P; Gomathi C; Swaminathan S
Antimicrob Agents Chemother; 2009 Mar; 53(3):863-8. PubMed ID: 19124658
[TBL] [Abstract][Full Text] [Related]
15. Influence of SLCO1B1 polymorphisms on lopinavir C
Dragović G; Dimitrijević B; Kušić J; Soldatović I; Jevtović D; Olagunju A; Owen A
Br J Clin Pharmacol; 2020 Jul; 86(7):1289-1295. PubMed ID: 32022294
[TBL] [Abstract][Full Text] [Related]
16. Frequency of the SLCO1B1 388A>G and the 521T>C polymorphism in Tanzania genotyped by a new LightCycler®-based method.
Aklillu E; Mugusi S; Ngaimisi E; Hoffmann MM; König S; Ziesenitz V; Mikus G; Haefeli WE; Weiss J
Eur J Clin Pharmacol; 2011 Nov; 67(11):1139-45. PubMed ID: 21630030
[TBL] [Abstract][Full Text] [Related]
17. Genetic Determinants of the Pharmacokinetic Variability of Rifampin in Malawian Adults with Pulmonary Tuberculosis.
Sloan DJ; McCallum AD; Schipani A; Egan D; Mwandumba HC; Ward SA; Waterhouse D; Banda G; Allain TJ; Owen A; Khoo SH; Davies GR
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461315
[TBL] [Abstract][Full Text] [Related]
18. SLCO1B1 Gene Variations Among Tanzanians, Ethiopians, and Europeans: Relevance for African and Worldwide Precision Medicine.
Aklillu E; Habtewold A; Ngaimisi E; Yimer G; Mugusi S; Amogne W; Reuter T; Meid A; Hoffmann MM; Weiss J
OMICS; 2016 Sep; 20(9):538-45. PubMed ID: 27631193
[TBL] [Abstract][Full Text] [Related]
19. [Associations of SLCO1B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients].
Liu S; Chen RX; Li J; Liu XM; Huang HB; Fu Q; Wang CX; Huang M; Li JL
Yao Xue Xue Bao; 2016 Aug; 51(8):1240-4. PubMed ID: 29897725
[TBL] [Abstract][Full Text] [Related]
20. SLCO1B1 c.521T>C Genotyping in the Austrian Population Using 2 Commercial Real-Time Polymerase Chain Reaction Assays: An Implementation Study.
Enko D; Harringer S; Oberkanins C; Pühringer H; Halwachs-Baumann G; Kriegshäuser G
Pharmacology; 2018; 102(1-2):88-90. PubMed ID: 29969773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]